Cargando…
Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
Multiple myeloma (MM) is a hematological malignancy characterized by clonal proliferation of plasma cells. Although therapeutic advances have been made to improve clinical outcomes and to prolong patients’ survival in the past two decades, MM remains largely incurable. Single-cell sequencing (SCS) i...
Autores principales: | Chen, Mengping, Jiang, Jinxing, Hou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234006/ https://www.ncbi.nlm.nih.gov/pubmed/37259170 http://dx.doi.org/10.1186/s40364-023-00502-8 |
Ejemplares similares
-
Distinct mechanisms of dysfunctional antigen‐presenting DCs and monocytes by single‐cell sequencing in multiple myeloma
por: Jiang, Jinxing, et al.
Publicado: (2023) -
A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
por: Chen, Xiaotong, et al.
Publicado: (2021) -
Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma
por: Chen, Mengping, et al.
Publicado: (2023) -
C-reactive protein impairs immune response of CD8(+) T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma
por: Jiang, Jinxing, et al.
Publicado: (2023) -
Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
por: Xiang, Jing, et al.
Publicado: (2022)